Not applicableStudy completedNCT07319767
What this trial is testing
Comparing the TDTP-RECIST With RECIST 1.1 and Other Volumetric Evaluation Methods for Assessing the Therapeutic Efficacy of Irregular Malignant Tumors
Who this might be right for
Breast CancerPancreatic Adenocarcinoma (Ductal Adenocarcinoma)Biliary Cancer (Cholangiocarcinoma, Gall Bladder Cancer)
Shanghai Zhongshan Hospital 120